Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Z Wang, H Zong, W Liu, W Lin, A Sun, Z Ding… - Journal of Experimental …, 2024 - Springer
Background The dysregulated mechanistic target of rapamycin complex 1 (mTORC1)
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential
Ferroptosis, a form of regulated cell death triggered by lipid hydroperoxide accumulation,
has an important role in a variety of diseases and pathological conditions, such as cancer …
has an important role in a variety of diseases and pathological conditions, such as cancer …
Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis
Ferroptosis, a form of regulated necrosis driven by iron-dependent peroxidation of
phospholipids, is regulated by cellular metabolism, redox homeostasis, and various …
phospholipids, is regulated by cellular metabolism, redox homeostasis, and various …
mTORC2 promotes cell survival through c-Myc–dependent up-regulation of E2F1
Z Zou, J Chen, A Liu, X Zhou, Q Song, C Jia… - Journal of Cell …, 2015 - rupress.org
Previous studies have reported that mTORC2 promotes cell survival through
phosphorylating AKT and enhancing its activity. We reveal another mechanism by which …
phosphorylating AKT and enhancing its activity. We reveal another mechanism by which …
Erk1/2-dependent HNSCC cell susceptibility to erastin-induced ferroptosis
D Savic, TB Steinbichler, J Ingruber, G Negro… - Cells, 2023 - mdpi.com
Unfavorable clinical outcomes mean that cancer researchers must attempt to develop novel
therapeutic strategies to overcome therapeutic resistance in patients with HNSCC. Recently …
therapeutic strategies to overcome therapeutic resistance in patients with HNSCC. Recently …
TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer
HL Zhang, BX Hu, ZP Ye, ZL Li, S Liu… - Science Translational …, 2024 - science.org
Targeting ferroptosis for cancer therapy has slowed because of an incomplete
understanding of ferroptosis mechanisms under specific pathological contexts such as …
understanding of ferroptosis mechanisms under specific pathological contexts such as …
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification
Y Xu, D Lv, C Yan, H Su, X Zhang, Y Shi, K Ying - Cancer cell international, 2022 - Springer
Abstract Background N6-methyladenosine (m6A) has emerged as a significant regulator of
the progress of various cancers. However, its role in lung adenocarcinoma (LUAD) remains …
the progress of various cancers. However, its role in lung adenocarcinoma (LUAD) remains …
Inhibition of CARM1‐Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer
S Feng, Z Rao, J Zhang, X She, Y Chen… - Advanced …, 2023 - Wiley Online Library
Ferroptosis, which is caused by iron‐dependent accumulation of lipid peroxides, is an
emerging form of regulated cell death and is considered a potential target for cancer …
emerging form of regulated cell death and is considered a potential target for cancer …
MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11
K Sun, W Ren, S Li, J Zheng, Y Huang, K Zhi… - Pathology-Research and …, 2022 - Elsevier
Background MiRNA is a small molecule RNA that plays an important role in a variety of
physiological and pathological processes., and miR-34c-3p has been demonstrated to be …
physiological and pathological processes., and miR-34c-3p has been demonstrated to be …
Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression
Y Qiao, M Su, H Zhao, H Liu, C Wang, X Dai… - Journal of Experimental …, 2024 - Springer
Ferroptosis is a newly identified iron-dependent form of death that is becoming increasingly
recognized as a promising avenue for cancer therapy. N6-methyladenosine (m6A) is the …
recognized as a promising avenue for cancer therapy. N6-methyladenosine (m6A) is the …